首页 > 最新文献

Colloids and Surfaces B: Biointerfaces最新文献

英文 中文
A multifunctional nanoplatform based on chlorin e6 for fluorescence imaging-guided sonodynamic and chemodynamic cancer therapy
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-21 DOI: 10.1016/j.colsurfb.2025.114718
Qi Xu , Fang He , Zhimin Mo , Han Hu , Qianyuan He , Zushun Xu , Shengli Yang , Xiaojuan Qin
Emerging multimodal therapy strategies based on sonodynamic therapy (SDT) are foreseen as foundational in forthcoming tumor theranostics. Nevertheless, the therapeutic effects of SDT are limited by the hypoxic environment of the tumor microenvironment (TME). Based on this, nano-enzymes are envisioned to decompose excess hydrogen peroxide in the tumor microenvironment to generate oxygen. Here, PEG-PLGA-coated CeO2 nanoparticles loaded with the sonosensitizer chlorin e6 (CC@PP) were prepared for cancer therapy based on a nanoprecipitation method. CC@PP possesses highly efficient catalase-like (CAT) properties, which are able to decompose overexpressed H2O2 into O2 and enhance the effect of O2-dependent sonodynamic therapy. In addition, it can act as a peroxidase (POD) at lower pH for chemodynamic therapy. Under the guidance of the US, CC@PP can perform synergistic sonodynamic and chemodynamic cancer therapy and inhibit tumor growth efficiently, CC@PP is biocompatible, has good in vivo fluorescence imaging effect, and has integrated diagnostic and therapeutic properties, which can be effectively aggregated at the tumor area. In this study, the effect of sonodynamic therapy was enhanced by improving the hypoxic environment in the TME, and multimodal synergistic enhancement of cancer therapy was realized.
{"title":"A multifunctional nanoplatform based on chlorin e6 for fluorescence imaging-guided sonodynamic and chemodynamic cancer therapy","authors":"Qi Xu ,&nbsp;Fang He ,&nbsp;Zhimin Mo ,&nbsp;Han Hu ,&nbsp;Qianyuan He ,&nbsp;Zushun Xu ,&nbsp;Shengli Yang ,&nbsp;Xiaojuan Qin","doi":"10.1016/j.colsurfb.2025.114718","DOIUrl":"10.1016/j.colsurfb.2025.114718","url":null,"abstract":"<div><div>Emerging multimodal therapy strategies based on sonodynamic therapy (SDT) are foreseen as foundational in forthcoming tumor theranostics. Nevertheless, the therapeutic effects of SDT are limited by the hypoxic environment of the tumor microenvironment (TME). Based on this, nano-enzymes are envisioned to decompose excess hydrogen peroxide in the tumor microenvironment to generate oxygen. Here, PEG-PLGA-coated CeO<sub>2</sub> nanoparticles loaded with the sonosensitizer chlorin e6 (CC@PP) were prepared for cancer therapy based on a nanoprecipitation method. CC@PP possesses highly efficient catalase-like (CAT) properties, which are able to decompose overexpressed H<sub>2</sub>O<sub>2</sub> into O<sub>2</sub> and enhance the effect of O<sub>2</sub>-dependent sonodynamic therapy. In addition, it can act as a peroxidase (POD) at lower pH for chemodynamic therapy. Under the guidance of the US, CC@PP can perform synergistic sonodynamic and chemodynamic cancer therapy and inhibit tumor growth efficiently, CC@PP is biocompatible, has good <em>in vivo</em> fluorescence imaging effect, and has integrated diagnostic and therapeutic properties, which can be effectively aggregated at the tumor area. In this study, the effect of sonodynamic therapy was enhanced by improving the hypoxic environment in the TME, and multimodal synergistic enhancement of cancer therapy was realized.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114718"},"PeriodicalIF":5.4,"publicationDate":"2025-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143859859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tannic acid-etched PAN/PVP nanofibers loaded with Cu-MOFs enhance antibacterial efficacy and accelerate wound healing
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114719
Zhenyu Wang , Jianxiang Li , Sihan Li , Diwei Li , Yunyi Zhao , Ling Xu , Gang Liu , Zhaoqiong Chen , Xiaoming Luo
Wound infection represents a prevalent and pressing clinical challenge, resulting in delayed wound healing and severe complications. In this study, a novel wound dressing was fabricated through a combination of electrospinning and acid etching techniques. First, nanofibers were fabricated by blending electrospun polyacrylonitrile/Polyvinylpyrrolidone (PAN/PVP) polymers with copper-based metal organic frameworks (Cu-MOFs). Subsequently, tannic acid was employed to etch the surface sites of Cu-MOFs on the fibers. The obtained nanofibers exhibited a typical porous structure, superior water absorption and gas permeability, with the average water vapor transmission rate was 2170.6 gm-2day-1. Additionally, the release behavior of copper ions can be modulated by altering the mass ratio of PVP to PAN, the amount of Cu-MOFs and the use of tannic acid. In vitro antibacterial assays revealed that the antibacterial efficacy of nanofibers increased with the addition of Cu-MOFs, after 48 hours of treatment, the inhibition rates of the nanofibers against E. coli and S. aureus reached over 79.5 % and 90 %, respectively. In vivo experiments demonstrated that these nanofibers alleviated wound inflammation and promoted collagen and angiogenesis, exhibition superior anti-inflammatory and wound-healing effects. The biosafety tests indicated that the nanofibers loaded with 1 % and 3 % Cu-MOFs exhibited good biocompatibility, while the nanofibers loaded with 5 % Cu-MOFs showed slight cytotoxicity. This study provides a novel strategy for the design and fabrication of advanced wound dressings in biomedical applications.
{"title":"Tannic acid-etched PAN/PVP nanofibers loaded with Cu-MOFs enhance antibacterial efficacy and accelerate wound healing","authors":"Zhenyu Wang ,&nbsp;Jianxiang Li ,&nbsp;Sihan Li ,&nbsp;Diwei Li ,&nbsp;Yunyi Zhao ,&nbsp;Ling Xu ,&nbsp;Gang Liu ,&nbsp;Zhaoqiong Chen ,&nbsp;Xiaoming Luo","doi":"10.1016/j.colsurfb.2025.114719","DOIUrl":"10.1016/j.colsurfb.2025.114719","url":null,"abstract":"<div><div>Wound infection represents a prevalent and pressing clinical challenge, resulting in delayed wound healing and severe complications. In this study, a novel wound dressing was fabricated through a combination of electrospinning and acid etching techniques. First, nanofibers were fabricated by blending electrospun polyacrylonitrile/Polyvinylpyrrolidone (PAN/PVP) polymers with copper-based metal organic frameworks (Cu-MOFs). Subsequently, tannic acid was employed to etch the surface sites of Cu-MOFs on the fibers. The obtained nanofibers exhibited a typical porous structure, superior water absorption and gas permeability, with the average water vapor transmission rate was 2170.6 gm<sup>-2</sup>day<sup>-1</sup>. Additionally, the release behavior of copper ions can be modulated by altering the mass ratio of PVP to PAN, the amount of Cu-MOFs and the use of tannic acid. <em>In vitro</em> antibacterial assays revealed that the antibacterial efficacy of nanofibers increased with the addition of Cu-MOFs, after 48 hours of treatment, the inhibition rates of the nanofibers against <em>E. coli</em> and <em>S. aureus</em> reached over 79.5 % and 90 %, respectively. <em>In vivo</em> experiments demonstrated that these nanofibers alleviated wound inflammation and promoted collagen and angiogenesis, exhibition superior anti-inflammatory and wound-healing effects. The biosafety tests indicated that the nanofibers loaded with 1 % and 3 % Cu-MOFs exhibited good biocompatibility, while the nanofibers loaded with 5 % Cu-MOFs showed slight cytotoxicity. This study provides a novel strategy for the design and fabrication of advanced wound dressings in biomedical applications.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114719"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143855698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microarc oxidation-PBAT composite coating on EK30 biodegradable magnesium alloys to enhance corrosion resistance and cytocompatibility
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114720
Weisheng Cao , Siyu Zhu , Weiqiang Wang , Yahui Wang , Shuaikang Yang , Haiyang Sun
The rapid degradation rate of biodegradable magnesium alloys restricts their use in medical implants. Therefore, designing a protective coating with a slow degradation rate and good biocompatibility is crucial. For biodegradable magnesium alloy stents, it is equally important to enhance the material's corrosion resistance and ensure the coating's deformation adaptability to the stent. This study, utilized a combination of micro-arc oxidation (MAO) and dip-coating techniques to develop a novel composite coating comprising an MAO base layer and a poly(butylene adipate-co-terephthalate) (PBAT) outer layer on EK30 magnesium alloy. This composite coating was designed to enhance the corrosion resistance and biocompatibility of EK30 magnesium alloy for stent applications. The surface characteristics, corrosion resistance, in vitro cytocompatibility, and deformation adaptability of the composite coating to the stent were evaluated. The MAO-PBAT composite coating demonstrated a low corrosion current density (Icorr = 2.381 ×10−8 A/cm2), three orders of magnitude lower than that of unmodified EK30 magnesium alloy. Live/dead cell staining results confirmed that the composite coating exhibited good cytocompatibility with human aortic endothelial cells (HAECs) and human aortic smooth muscle cells (HASMCs). Observations of the stent treated with the composite coating during crimping and expansion showed that the composite coating possessed excellent deformation adaptability. These results indicate that the MAO-PBAT composite coating has significant potential for vascular stent application.
{"title":"Microarc oxidation-PBAT composite coating on EK30 biodegradable magnesium alloys to enhance corrosion resistance and cytocompatibility","authors":"Weisheng Cao ,&nbsp;Siyu Zhu ,&nbsp;Weiqiang Wang ,&nbsp;Yahui Wang ,&nbsp;Shuaikang Yang ,&nbsp;Haiyang Sun","doi":"10.1016/j.colsurfb.2025.114720","DOIUrl":"10.1016/j.colsurfb.2025.114720","url":null,"abstract":"<div><div>The rapid degradation rate of biodegradable magnesium alloys restricts their use in medical implants. Therefore, designing a protective coating with a slow degradation rate and good biocompatibility is crucial. For biodegradable magnesium alloy stents, it is equally important to enhance the material's corrosion resistance and ensure the coating's deformation adaptability to the stent. This study, utilized a combination of micro-arc oxidation (MAO) and dip-coating techniques to develop a novel composite coating comprising an MAO base layer and a poly(butylene adipate-co-terephthalate) (PBAT) outer layer on EK30 magnesium alloy. This composite coating was designed to enhance the corrosion resistance and biocompatibility of EK30 magnesium alloy for stent applications. The surface characteristics, corrosion resistance, <em>in vitro</em> cytocompatibility, and deformation adaptability of the composite coating to the stent were evaluated. The MAO-PBAT composite coating demonstrated a low corrosion current density (<em>I</em><sub>corr</sub> = 2.381 ×10<sup>−8</sup> A/cm<sup>2</sup>), three orders of magnitude lower than that of unmodified EK30 magnesium alloy. Live/dead cell staining results confirmed that the composite coating exhibited good cytocompatibility with human aortic endothelial cells (HAECs) and human aortic smooth muscle cells (HASMCs). Observations of the stent treated with the composite coating during crimping and expansion showed that the composite coating possessed excellent deformation adaptability. These results indicate that the MAO-PBAT composite coating has significant potential for vascular stent application.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114720"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143851930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineered bacterial outer membrane vesicles co-delivering Angio-3 and doxorubicin to enhance tumor therapy
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114707
Shuai Zhao , Wenxuan Xu , Wanting Zeng , Shuailin He , Xuan Luo , Dejie Ge , Yamin Duan , Rui Han , Chin-Yu Chen , Yong Yang , Yunhong Hu , Cheng Zhang
Bacterial outer membrane vesicles (OMVs) have emerged as versatile nanomaterial-based drug delivery systems that can stimulate systemic immune responses and facilitate precise co-delivery of multiple therapeutic agents. This study introduces a bioengineering approach that enables the co-delivery of the angiogenesis inhibitor Angio-3 and the chemotherapeutic agent doxorubicin (DOX) within OMVs, creating a potent antitumor therapeutic platform. Angio-3 displayed on the surface of OMVs inhibited angiogenesis and decreased vascular permeability, which in turn impeded the supply of nutrients necessary for tumor growth. Moreover, intrinsic properties of OMVs triggered a systemic immune response. Both in vitro and in vivo studies, including a CT26 tumor-bearing mouse model, have demonstrated that the OMV@A&D-based therapeutic regimen, which integrates antiangiogenesis, chemotherapy, and immune activation, significantly suppresses tumor proliferation. This study highlights the potential of bioengineered OMVs in revolutionizing cancer therapy by offering a multifaceted and synergistic platform that enhances therapeutic outcomes.
{"title":"Engineered bacterial outer membrane vesicles co-delivering Angio-3 and doxorubicin to enhance tumor therapy","authors":"Shuai Zhao ,&nbsp;Wenxuan Xu ,&nbsp;Wanting Zeng ,&nbsp;Shuailin He ,&nbsp;Xuan Luo ,&nbsp;Dejie Ge ,&nbsp;Yamin Duan ,&nbsp;Rui Han ,&nbsp;Chin-Yu Chen ,&nbsp;Yong Yang ,&nbsp;Yunhong Hu ,&nbsp;Cheng Zhang","doi":"10.1016/j.colsurfb.2025.114707","DOIUrl":"10.1016/j.colsurfb.2025.114707","url":null,"abstract":"<div><div>Bacterial outer membrane vesicles (OMVs) have emerged as versatile nanomaterial-based drug delivery systems that can stimulate systemic immune responses and facilitate precise co-delivery of multiple therapeutic agents. This study introduces a bioengineering approach that enables the co-delivery of the angiogenesis inhibitor Angio-3 and the chemotherapeutic agent doxorubicin (DOX) within OMVs, creating a potent antitumor therapeutic platform. Angio-3 displayed on the surface of OMVs inhibited angiogenesis and decreased vascular permeability, which in turn impeded the supply of nutrients necessary for tumor growth. Moreover, intrinsic properties of OMVs triggered a systemic immune response. Both <em>in vitro</em> and <em>in vivo</em> studies, including a CT26 tumor-bearing mouse model, have demonstrated that the OMV@A&amp;D-based therapeutic regimen, which integrates antiangiogenesis, chemotherapy, and immune activation, significantly suppresses tumor proliferation. This study highlights the potential of bioengineered OMVs in revolutionizing cancer therapy by offering a multifaceted and synergistic platform that enhances therapeutic outcomes.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114707"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143851928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quaternized chitosan-based injectable self-healing hydrogel for improving wound management in aging populations
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114721
Guochang Chen , Xiaowei Xun , Haiyong Ao , Ziqing Chen , Dingyun Wang , Maohu Wang , Dongxue Zhang , Minzhuo Liu , Guanghua Guo
The clinical management and treatment of skin wounds in the elderly present significant challenges due to changes in skin structure and function. This study introduces a novel injectable self-healing hydrogel composed of quaternized chitosan and carboxymethyl chitosan (HACC/CMCS, HC), designed through electrostatic interactions. Its excellent injectability and self-healing properties enhance the application of hydrogel dressings and prolong their functional lifespan. Moreover, the adhesion and flexibility of HC hydrogel contribute to their stability in highly dynamic regions, thereby preventing detachment and enhancing their hemostatic function. The material exhibits excellent biocompatibility and possesses antibacterial properties that protect wounds from external microbial damage, thereby reducing the risk of infection while maintaining a moist environment that facilitates healing. Importantly, the in vivo test have demonstrated that the HC hydrogel significantly enhances collagen deposition, reduces senescent cell accumulation, and accelerates wound closure. Therefore, this study offers a safe, effective, and cost-efficient solution for managing wounds in the aging population.
{"title":"Quaternized chitosan-based injectable self-healing hydrogel for improving wound management in aging populations","authors":"Guochang Chen ,&nbsp;Xiaowei Xun ,&nbsp;Haiyong Ao ,&nbsp;Ziqing Chen ,&nbsp;Dingyun Wang ,&nbsp;Maohu Wang ,&nbsp;Dongxue Zhang ,&nbsp;Minzhuo Liu ,&nbsp;Guanghua Guo","doi":"10.1016/j.colsurfb.2025.114721","DOIUrl":"10.1016/j.colsurfb.2025.114721","url":null,"abstract":"<div><div>The clinical management and treatment of skin wounds in the elderly present significant challenges due to changes in skin structure and function. This study introduces a novel injectable self-healing hydrogel composed of quaternized chitosan and carboxymethyl chitosan (HACC/CMCS, HC), designed through electrostatic interactions. Its excellent injectability and self-healing properties enhance the application of hydrogel dressings and prolong their functional lifespan. Moreover, the adhesion and flexibility of HC hydrogel contribute to their stability in highly dynamic regions, thereby preventing detachment and enhancing their hemostatic function. The material exhibits excellent biocompatibility and possesses antibacterial properties that protect wounds from external microbial damage, thereby reducing the risk of infection while maintaining a moist environment that facilitates healing. Importantly, the <em>in vivo</em> test have demonstrated that the HC hydrogel significantly enhances collagen deposition, reduces senescent cell accumulation, and accelerates wound closure. Therefore, this study offers a safe, effective, and cost-efficient solution for managing wounds in the aging population.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114721"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143859858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Marine polysaccharides hydrogel with encapsulated mesalazine for the treatment of ulcerative colitis: Integrative effects on inflammation, microbiota, and mucosal repair
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114722
Teng Xiao , Zhenxin Yu , Haomin Yang , Jun You , Xiaochen Wu
Ulcerative colitis is a chronic non-specific inflammatory disease of the intestine that significantly impacts patient quality of life. This study introduces a OF/CC/SM hydrogel containing oxidized fucoidan (OF), carboxymethyl chitosan (CC), and silk sericin-stabilized mesalazine (SM), designed for rectal administration to target mesalazine delivery specifically to the colon. The OF/CC/SM hydrogel demonstrated good biocompatibility (cell compatibility > 99 %), injectability, and adhesion strength, ensuring effective mesalazine retention and release. In vitro assays confirmed the hydrogel's antioxidant and anti-inflammatory properties, which were further validated in vivo using a mouse model of ulcerative colitis. Rectal administration of OF/CC/SM hydrogel significantly relieved weight loss, lowered disease activity index scores, and prevented intestinal shortening associated with dextran sulfate sodium (DSS) treatment. The hydrogel decreased the expression of proinflammatory cytokines (e.g., tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)), while normalized the level of biomarkers (e.g., inducible nitric oxide synthase (iNOS), myeloperoxidase (MPO), catalase (CAT), and malondialdehyde (MDA)). Additionally, the OF/CC/SM hydrogel modulated the gut microbiota, increasing beneficial bacteria while decreasing potentially harmful species. Histopathological analysis revealed a reduction in inflammatory infiltration and improved mucosal architecture. Additionally, in vivo imaging studies confirmed sustained presence of OF/CC/SM hydrogel in the intestines following rectal administration, highlighting its potential for enhanced therapeutic efficacy in treating ulcerative colitis.
{"title":"Marine polysaccharides hydrogel with encapsulated mesalazine for the treatment of ulcerative colitis: Integrative effects on inflammation, microbiota, and mucosal repair","authors":"Teng Xiao ,&nbsp;Zhenxin Yu ,&nbsp;Haomin Yang ,&nbsp;Jun You ,&nbsp;Xiaochen Wu","doi":"10.1016/j.colsurfb.2025.114722","DOIUrl":"10.1016/j.colsurfb.2025.114722","url":null,"abstract":"<div><div>Ulcerative colitis is a chronic non-specific inflammatory disease of the intestine that significantly impacts patient quality of life. This study introduces a OF/CC/SM hydrogel containing oxidized fucoidan (OF), carboxymethyl chitosan (CC), and silk sericin-stabilized mesalazine (SM), designed for rectal administration to target mesalazine delivery specifically to the colon. The OF/CC/SM hydrogel demonstrated good biocompatibility (cell compatibility &gt; 99 %), injectability, and adhesion strength, ensuring effective mesalazine retention and release. <em>In vitro</em> assays confirmed the hydrogel's antioxidant and anti-inflammatory properties, which were further validated <em>in vivo</em> using a mouse model of ulcerative colitis. Rectal administration of OF/CC/SM hydrogel significantly relieved weight loss, lowered disease activity index scores, and prevented intestinal shortening associated with dextran sulfate sodium (DSS) treatment. The hydrogel decreased the expression of proinflammatory cytokines (e.g., tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β)), while normalized the level of biomarkers (e.g., inducible nitric oxide synthase (iNOS), myeloperoxidase (MPO), catalase (CAT), and malondialdehyde (MDA)). Additionally, the OF/CC/SM hydrogel modulated the gut microbiota, increasing beneficial bacteria while decreasing potentially harmful species. Histopathological analysis revealed a reduction in inflammatory infiltration and improved mucosal architecture. Additionally, <em>in vivo</em> imaging studies confirmed sustained presence of OF/CC/SM hydrogel in the intestines following rectal administration, highlighting its potential for enhanced therapeutic efficacy in treating ulcerative colitis.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114722"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143851929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of phenolic hydroxyl group structures of Alaska pollock gelatin-based adhesives on soft tissue adhesion and biocompatibility
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-18 DOI: 10.1016/j.colsurfb.2025.114715
Mari Miyata , Hiyori Komatsu , Shima Ito , Shiharu Watanabe , Satsuki Minamisakamoto , Tetsushi Taguchi
Marine mussels adhere to various types of substrates in aqueous/wet environments, and their adhesion is controlled by the catechol structure of the phenolic hydroxyl groups. Tissue adhesives with a catechol structure have been designed based on this biomimetic adhesion mechanism. However, the effects of the chemical structure of the phenolic hydroxyl groups on tissue adhesion and biocompatibility have not yet been systematically investigated. In this study, various phenolic hydroxyl group-modified Alaska pollock gelatins (nHy-ApGltns (n = 0, 1, 2, 3)) were synthesized and their function as tissue adhesives with a poly(ethylene glycol)-based 4-armed crosslinker (4S-PEG) was evaluated. The nHy-ApGltn adhesives showed increases in bulk strength and decreases in swelling compared to the original-ApGltn (Org-ApGltn) adhesive. The tensile stress and Young's modulus of the nHy-ApGltn adhesives increased with the introduction of nHy groups. The burst strength of the nHy-ApGltn adhesives had a maximum value at each content; however, a high content of nHy in the nHy-ApGltn adhesives had a negative effect on the burst strength. The burst strength of the porcine aorta with all the nHy-ApGltn adhesives was higher than that with human blood pressure. From histological observations after burst strength measurements, the 2Hy- and 3Hy-ApGltn adhesives showed stable interfacial adhesion compared to the Org-, 0Hy-, and 1Hy-ApGltn adhesives. The nHy-ApGltn (n = 0, 3) adhesives implanted subcutaneously in rats completely degraded within 64 days without severe inflammation or foreign body reactions. Therefore, nHy-ApGltn adhesives with low nHy content have excellent tissue adhesion and biocompatibility in wet environments and have the potential for use in biomedical applications.
{"title":"Effects of phenolic hydroxyl group structures of Alaska pollock gelatin-based adhesives on soft tissue adhesion and biocompatibility","authors":"Mari Miyata ,&nbsp;Hiyori Komatsu ,&nbsp;Shima Ito ,&nbsp;Shiharu Watanabe ,&nbsp;Satsuki Minamisakamoto ,&nbsp;Tetsushi Taguchi","doi":"10.1016/j.colsurfb.2025.114715","DOIUrl":"10.1016/j.colsurfb.2025.114715","url":null,"abstract":"<div><div>Marine mussels adhere to various types of substrates in aqueous/wet environments, and their adhesion is controlled by the catechol structure of the phenolic hydroxyl groups. Tissue adhesives with a catechol structure have been designed based on this biomimetic adhesion mechanism. However, the effects of the chemical structure of the phenolic hydroxyl groups on tissue adhesion and biocompatibility have not yet been systematically investigated. In this study, various phenolic hydroxyl group-modified Alaska pollock gelatins (nHy-ApGltns (n = 0, 1, 2, 3)) were synthesized and their function as tissue adhesives with a poly(ethylene glycol)-based 4-armed crosslinker (4S-PEG) was evaluated. The nHy-ApGltn adhesives showed increases in bulk strength and decreases in swelling compared to the original-ApGltn (Org-ApGltn) adhesive. The tensile stress and Young's modulus of the nHy-ApGltn adhesives increased with the introduction of nHy groups. The burst strength of the nHy-ApGltn adhesives had a maximum value at each content; however, a high content of nHy in the nHy-ApGltn adhesives had a negative effect on the burst strength. The burst strength of the porcine aorta with all the nHy-ApGltn adhesives was higher than that with human blood pressure. From histological observations after burst strength measurements, the 2Hy- and 3Hy-ApGltn adhesives showed stable interfacial adhesion compared to the Org-, 0Hy-, and 1Hy-ApGltn adhesives. The nHy-ApGltn (n = 0, 3) adhesives implanted subcutaneously in rats completely degraded within 64 days without severe inflammation or foreign body reactions. Therefore, nHy-ApGltn adhesives with low nHy content have excellent tissue adhesion and biocompatibility in wet environments and have the potential for use in biomedical applications.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114715"},"PeriodicalIF":5.4,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143855697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sulfonated covalent organic frameworks (COF)/polyethersulfone (PES) membrane with enhanced hemocompatibility for blood oxygenation
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-16 DOI: 10.1016/j.colsurfb.2025.114716
Yue Huang , Lunhao Zhi , Chong Cheng , Qiang Wei , Shudong Sun , Changsheng Zhao
In extracorporeal membrane oxygenation (ECMO) treatment, designing membrane with self-anticoagulant properties can solve problems resulting from the adverse effect of anticoagulants. In this study, 2,4,6-Triformylphloroglucinol (Tp) and 2,5-Diaminobenzenesulfonic acid (Pa-SO3H) were applied to grow a sulfonated COF film in situ on the polyethersulfone (PES) membrane. The introduction of sulfonic groups increased the hydrophilicity and electronegativity of the TpPa COF film, improved its anti-protein adhesion properties, maintained the normal morphology of blood cells, and endowed the COF film with antithrombotic properties. In the porcine blood circulation test, the duration to increase So2 (O2 saturation) from ∼75–95 % in TpPa-SO3H COF/PES membrane (M-TpPa-SO3H) was 70 min shorter than that in TpPa COF/PES membrane (M-TpPa). This preparation method is applicable to the preparation of not only flat membranes, but also hollow fiber membranes. These findings emphasize the potential of M-TpPa-SO3H in ECMO applications, providing superior antithrombotic property and CO2 efflux potential.
{"title":"Sulfonated covalent organic frameworks (COF)/polyethersulfone (PES) membrane with enhanced hemocompatibility for blood oxygenation","authors":"Yue Huang ,&nbsp;Lunhao Zhi ,&nbsp;Chong Cheng ,&nbsp;Qiang Wei ,&nbsp;Shudong Sun ,&nbsp;Changsheng Zhao","doi":"10.1016/j.colsurfb.2025.114716","DOIUrl":"10.1016/j.colsurfb.2025.114716","url":null,"abstract":"<div><div>In extracorporeal membrane oxygenation (ECMO) treatment, designing membrane with self-anticoagulant properties can solve problems resulting from the adverse effect of anticoagulants. In this study, 2,4,6-Triformylphloroglucinol (Tp) and 2,5-Diaminobenzenesulfonic acid (Pa-SO<sub>3</sub>H) were applied to grow a sulfonated COF film in situ on the polyethersulfone (PES) membrane. The introduction of sulfonic groups increased the hydrophilicity and electronegativity of the TpPa COF film, improved its anti-protein adhesion properties, maintained the normal morphology of blood cells, and endowed the COF film with antithrombotic properties. In the porcine blood circulation test, the duration to increase So<sub>2</sub> (O<sub>2</sub> saturation) from ∼75–95 % in TpPa-SO<sub>3</sub>H COF/PES membrane (M-TpPa-SO<sub>3</sub>H) was 70 min shorter than that in TpPa COF/PES membrane (M-TpPa). This preparation method is applicable to the preparation of not only flat membranes, but also hollow fiber membranes. These findings emphasize the potential of M-TpPa-SO<sub>3</sub>H in ECMO applications, providing superior antithrombotic property and CO<sub>2</sub> efflux potential.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114716"},"PeriodicalIF":5.4,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143844460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dual-action MOF-on-MOF hydrogel: A chemo-photodynamic strategy for enhanced antibacterial activity and infected wound healing
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-16 DOI: 10.1016/j.colsurfb.2025.114712
Yuze Dong , Jiahang Si , Jie Feng, Tiantian Xu, Xinyu Xiao, Yalan Ji, Ruikang Zhang, Xiaohan Sun, Yingnan Zhu
Open skin wounds are susceptible to bacterial infections, which can delay healing and even trigger life-threatening complications. The improper and prolonged use of antibiotics can accelerate bacterial resistance, complicating the treatment of clinical infections. Therefore, there is an urgent need for effective antibiotic-free therapeutic strategies to treat bacterial infections in wounds. In this study, we loaded the growth factor Dimethyloxalylglycine (DMOG) into the pores of PCN-224 and subsequently deposited 2-Methylimidazole zinc salt (ZIF-8) on its surface, creating an injectable hydrogel based on a MOF-on-MOF design. This approach leverages metal ion release in conjunction with photodynamic therapy (PDT) to achieve effective antibacterial activity. Additionally, the injectable hydrogel can adapt to various wound morphologies and enable hemostasis for acute tissue injuries due to its fast gelation speed and adhesiveness. Meanwhile, the sustained release of DMOG promotes angiogenesis. Results demonstrated that the GelMA/HA/DMOG@PCN-224/ZIF-8 (GelMA/HA/D@PZ) hydrogel achieves a 99.9 % bactericidal rate against Staphylococcus aureus, Escherichia coli, and MRSA, while also significantly promoting the healing of infected wounds. Therefore, the GelMA/HA/D@PZ composite material facilitates initial hemostasis, mid-term antibacterial activity, and long-term angiogenesis, providing a novel, efficient, and safe approach to promote the healing of infected wounds.
{"title":"Dual-action MOF-on-MOF hydrogel: A chemo-photodynamic strategy for enhanced antibacterial activity and infected wound healing","authors":"Yuze Dong ,&nbsp;Jiahang Si ,&nbsp;Jie Feng,&nbsp;Tiantian Xu,&nbsp;Xinyu Xiao,&nbsp;Yalan Ji,&nbsp;Ruikang Zhang,&nbsp;Xiaohan Sun,&nbsp;Yingnan Zhu","doi":"10.1016/j.colsurfb.2025.114712","DOIUrl":"10.1016/j.colsurfb.2025.114712","url":null,"abstract":"<div><div>Open skin wounds are susceptible to bacterial infections, which can delay healing and even trigger life-threatening complications. The improper and prolonged use of antibiotics can accelerate bacterial resistance, complicating the treatment of clinical infections. Therefore, there is an urgent need for effective antibiotic-free therapeutic strategies to treat bacterial infections in wounds. In this study, we loaded the growth factor Dimethyloxalylglycine (DMOG) into the pores of PCN-224 and subsequently deposited 2-Methylimidazole zinc salt (ZIF-8) on its surface, creating an injectable hydrogel based on a MOF-on-MOF design. This approach leverages metal ion release in conjunction with photodynamic therapy (PDT) to achieve effective antibacterial activity. Additionally, the injectable hydrogel can adapt to various wound morphologies and enable hemostasis for acute tissue injuries due to its fast gelation speed and adhesiveness. Meanwhile, the sustained release of DMOG promotes angiogenesis. Results demonstrated that the GelMA/HA/DMOG@PCN-224/ZIF-8 (GelMA/HA/D@PZ) hydrogel achieves a 99.9 % bactericidal rate against Staphylococcus aureus, Escherichia coli, and MRSA, while also significantly promoting the healing of infected wounds. Therefore, the GelMA/HA/D@PZ composite material facilitates initial hemostasis, mid-term antibacterial activity, and long-term angiogenesis, providing a novel, efficient, and safe approach to promote the healing of infected wounds.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114712"},"PeriodicalIF":5.4,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143860510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
3D-printed scaffolds: Incorporating dexamethasone microspheres and BMP2 for enhanced osteogenic differentiation of human mesenchymal stem cells
IF 5.4 2区 医学 Q1 BIOPHYSICS Pub Date : 2025-04-16 DOI: 10.1016/j.colsurfb.2025.114705
Jung Hyun Noh , Yejin Lee , Moon Suk Kim
This study investigates the fabrication and evaluation of 3D-printed scaffolds (G-scaffolds) incorporating dexamethasone-loaded microspheres (Dex-M) and bone morphogenetic protein 2 (BMP2) to enhance osteogenic differentiation of human mesenchymal stem cells (hMSCs). Dex-M was prepared using an ultrasonic atomizer, achieving a high encapsulation efficiency and uniform particle size. The G-scaffolds were precisely printed using photoactive bioprinting, creating Dex-M+BMP2 +G-scaffolds. In vitro release studies demonstrated sustained Dex release over 6 weeks, with the Dex-M+BMP2 +G-scaffold significantly reducing the initial burst release and maintaining stable levels of osteogenic factors. Cytotoxicity assays confirmed the biocompatibility of the scaffolds, showing no adverse effects on hMSC viability. Osteogenic differentiation was assessed via RT-PCR, revealing that the Dex-M+BMP2 +G-scaffold exhibited the highest expression levels of critical osteogenic markers (ON, OP, OC, and COL1A) compared with the other scaffold formulations. Calcium deposition and elemental analysis also demonstrated enhanced mineralization in the Dex-M+BMP2 +G-scaffold group, with calcium and phosphate levels 3.9–1.7 times higher than in the other groups. Overall, the Dex-M+BMP2 +G-scaffold effectively promoted osteogenic differentiation and mineralization of hMSCs, underscoring its potential as a promising biomaterial for bone tissue engineering applications.
{"title":"3D-printed scaffolds: Incorporating dexamethasone microspheres and BMP2 for enhanced osteogenic differentiation of human mesenchymal stem cells","authors":"Jung Hyun Noh ,&nbsp;Yejin Lee ,&nbsp;Moon Suk Kim","doi":"10.1016/j.colsurfb.2025.114705","DOIUrl":"10.1016/j.colsurfb.2025.114705","url":null,"abstract":"<div><div>This study investigates the fabrication and evaluation of 3D-printed scaffolds (G-scaffolds) incorporating dexamethasone-loaded microspheres (Dex-M) and bone morphogenetic protein 2 (BMP2) to enhance osteogenic differentiation of human mesenchymal stem cells (hMSCs). Dex-M was prepared using an ultrasonic atomizer, achieving a high encapsulation efficiency and uniform particle size. The G-scaffolds were precisely printed using photoactive bioprinting, creating Dex-M+BMP2 +G-scaffolds. In vitro release studies demonstrated sustained Dex release over 6 weeks, with the Dex-M+BMP2 +G-scaffold significantly reducing the initial burst release and maintaining stable levels of osteogenic factors. Cytotoxicity assays confirmed the biocompatibility of the scaffolds, showing no adverse effects on hMSC viability. Osteogenic differentiation was assessed via RT-PCR, revealing that the Dex-M+BMP2 +G-scaffold exhibited the highest expression levels of critical osteogenic markers (ON, OP, OC, and COL1A) compared with the other scaffold formulations. Calcium deposition and elemental analysis also demonstrated enhanced mineralization in the Dex-M+BMP2 +G-scaffold group, with calcium and phosphate levels 3.9–1.7 times higher than in the other groups. Overall, the Dex-M+BMP2 +G-scaffold effectively promoted osteogenic differentiation and mineralization of hMSCs, underscoring its potential as a promising biomaterial for bone tissue engineering applications.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"253 ","pages":"Article 114705"},"PeriodicalIF":5.4,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143855699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colloids and Surfaces B: Biointerfaces
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1